SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CORALLINI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.276
EU - Europa 564
AS - Asia 474
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.275
CN - Cina 298
UA - Ucraina 185
TR - Turchia 110
GB - Regno Unito 98
IT - Italia 95
DE - Germania 90
SG - Singapore 53
FI - Finlandia 44
SE - Svezia 32
CZ - Repubblica Ceca 9
FR - Francia 6
IR - Iran 5
AU - Australia 3
BE - Belgio 2
ID - Indonesia 2
IN - India 2
CA - Canada 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
MY - Malesia 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 4.318
Salva come PNG Salva come JPEG
Città #
Fairfield 505
Woodbridge 470
Houston 264
Ashburn 222
Ann Arbor 221
Seattle 221
Chandler 211
Jacksonville 209
Cambridge 183
Wilmington 166
Beijing 68
Nanjing 68
Izmir 66
Princeton 47
New York 45
San Diego 35
Boardman 34
Singapore 32
Milan 31
Shanghai 25
Shenyang 25
Nanchang 23
Ferrara 19
Los Angeles 14
Changsha 13
Falls Church 13
Jinan 13
San Mateo 13
Auburn Hills 11
Hebei 11
Mountain View 11
Zhengzhou 11
Tianjin 10
Dearborn 9
Bremen 7
Brno 7
Philadelphia 7
Haikou 6
Redwood City 6
Kunming 5
Norwalk 5
Tappahannock 5
Ardabil 4
Leawood 4
London 4
Augusta 3
Changchun 3
Des Moines 3
Jiaxing 3
Munich 3
Padova 3
Taizhou 3
Verona 3
Walnut 3
Brussels 2
Castelnuovo Scrivia 2
Guangzhou 2
Hangzhou 2
Helsinki 2
Hounslow 2
Kilburn 2
Ningbo 2
Prescot 2
Redmond 2
San Francisco 2
Washington 2
Acton 1
Addison 1
Amsterdam 1
Atlanta 1
Cascina 1
Clearwater 1
Edinburgh 1
Forest City 1
Frankfurt am Main 1
Indiana 1
Jakarta 1
Kuantan 1
Logan 1
Monmouth Junction 1
New Bedfont 1
Olomouc 1
Orange 1
Prague 1
Pune 1
Salerno 1
Sandston 1
Shaoxing 1
Southwark 1
Stockholm 1
Sydney 1
Taiyuan 1
Tel Aviv 1
Torino 1
Toronto 1
Trieste 1
Xian 1
Zagreb 1
Totale 3.462
Salva come PNG Salva come JPEG
Nome #
Potential role of PKC inhibitors in the treatment of hematological malignancies 132
Antiangiogenic activity of the MDM2 antagonist nutlin-3 128
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 126
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 124
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 124
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 121
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 117
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 117
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 114
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies. 111
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 111
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 109
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. 109
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 108
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 107
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 107
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 105
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 105
null 102
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 102
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 102
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 101
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 99
null 97
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 97
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 96
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 96
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 95
null 94
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 92
null 90
null 89
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 89
null 88
null 86
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 86
Activation of the p53 pathway down-regulates the osteoprotegerin (OPG) expression and release by vascular endothelial cells. 80
null 78
null 74
null 65
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 58
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 37
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 29
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 28
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 24
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 19
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 18
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 17
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 16
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 14
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 12
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 7
Totale 4.352
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.151 172 45 41 171 83 121 107 118 89 125 58 21
2020/2021566 49 55 19 90 20 56 15 73 16 68 75 30
2021/2022522 15 57 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 4.352